Why the study?
Does intramyocardial implantation of stromal vascular fraction demonstrate safety and improve outcomes in patients with chronic ischemic cardiomyopathy?
Does intramyocardial implantation of stromal vascular fraction demonstrate safety and improve outcomes in patients with chronic ischemic cardiomyopathy?
Intramyocardial implantation of stromal vascular fraction appears safe and well-tolerated in patients with chronic ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports further trials; does not yet inform clinical use in chronic ischemic cardiomyopathy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Comella et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: